Systemic sclerosis (SSc) is a slowly progressive disease that is characterized by vasculopathy, fibrosis of the skin and visceral organs, immune rearrangement, and B-cell activation with specific autoantibodies.(1) The lung and skin are the most commonly seen tumor sites in patients with SSc, which are usually affected by both fibrosis and underlyi